Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer

Ertan E., OĞUZ SOYDİNÇ H., YAZAR A., Ustuner Z., TAŞ F., Yasasever V.

TUMORI, cilt.97, sa.3, ss.286-289, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 97 Sayı: 3
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1700/912.10023
  • Dergi Adı: TUMORI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.286-289
  • Anahtar Kelimeler: chemotherapy, matrix metalloproteinase-9, non-small cell lung cancer, ENDOTHELIAL GROWTH-FACTOR, SERUM-LEVELS, EXPRESSION, MMP-9, ADENOCARCINOMA, PROGNOSIS, SURVIVAL
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Aims and background. The aim of the study was to investigate the alteration in serum matrix metalloproteinase-9 (MMP-9) levels after chemotherapy and the association between the changes in serum levels of MMP-9 and response to chemotherapy in patients with advanced stage non-small cell lung cancer.